TCI Wealth Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-61
Closed -$3.46K 1012
2023
Q1
$3.46K Sell
61
-70
-53% -$4.49K ﹤0.01% 1771
2022
Q4
$9.73K Buy
131
+70
+115% +$4.77K ﹤0.01% 1089
2022
Q3
$4K Buy
61
+3
+5% +$181 ﹤0.01% 1605
2022
Q2
$3K Hold
58
﹤0.01% 1802
2022
Q1
$4K Hold
58
﹤0.01% 1701
2021
Q4
$4K Hold
58
﹤0.01% 1816
2021
Q3
$4K Hold
58
﹤0.01% 1743
2021
Q2
$4K Hold
58
﹤0.01% 1573
2021
Q1
$4K Hold
58
﹤0.01% 1371
2020
Q4
$4K Buy
58
+51
+729% +$2.93K ﹤0.01% 963
2020
Q3
$0 Buy
+7
New +$361 ﹤0.01% 1575

Other funds holding GMED

TCI Wealth Advisors's GMED Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Globus Medical (GMED) in Q2 2023, closing a stake of 61 shares — an estimated $3.46K sold.

TCI Wealth Advisors first reported a position in GMED in Q3 2020 and held it in 11 quarters. The position peaked at $9.73K in Q4 2022. 382 funds tracked by Wall St. Rank hold GMED as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Globus Medical position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 61 Globus Medical shares in Q2 2023, an estimated $3.46K.
  • TCI Wealth Advisors first reported a position in Globus Medical in Q3 2020 and held it in 11 quarters.
  • TCI Wealth Advisors's Globus Medical position peaked at $9.73K in Q4 2022.
  • 382 funds tracked by Wall St. Rank held Globus Medical as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.